Moderna AFS and Trading Securities - Unrealized Loss Position Fair Value increased by 175.0% to $11.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $13.00M to $11.00M. Over 4 years (FY 2021 to FY 2025), AFS and Trading Securities - Unrealized Loss Position Fair Value shows a downward trend with a -47.3% CAGR.
afs_trading_securities_unrealized_loss_fv| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $52.00M | $271.00M | $378.00M | $549.00M | $464.00M | $348.00M | $335.00M | $268.00M | $151.00M | $125.00M | $94.00M | $34.00M | $28.00M | $13.00M | $9.00M | $5.00M | $4.00M | $11.00M |
| QoQ Change | — | +421.2% | +39.5% | +45.2% | -15.5% | -25.0% | -3.7% | -20.0% | -43.7% | -17.2% | -24.8% | -63.8% | -17.6% | -53.6% | -30.8% | -44.4% | -20.0% | +175.0% |
| YoY Change | — | — | — | — | +792.3% | +28.4% | -11.4% | -51.2% | -67.5% | -64.1% | -71.9% | -87.3% | -81.5% | -89.6% | -90.4% | -85.3% | -85.7% | -15.4% |